http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22916687

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 6163
issn 1557-3265
1078-0432
issueIdentifier 24
pageRange 6153-6163
publicationName Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage 6153
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7c06f1f1553db51882f94110b7c49f46
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0352fa9dbf5677f98c9a97bb83d9d515
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_02febdfabb01431587f98404a98ef30e
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_de42e65a0bc47a844b2b7ac953cc25b6
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5b6ec36b65f92b6451b126ef2b7ceeeb
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8228aba572b4af9b66e6d2c1c35d1b03
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_20e78c354bdcd25837e64cd597aca71d
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3816e42280737611cc10dcd7b1e16f7f
bibliographicCitation Beglyarova N, Banina E, Zhou Y, Mukhamadeeva R, Andrianov G, Bobrov E, Lysenko E, Skobeleva N, Gabitova L, Restifo D, Pressman M, Serebriiskii IG, Hoffman JP, Paz K, Behrens D, Khazak V, Jablonski SA, Golemis EA, Weiner LM, Astsaturov I. Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer. Clin Cancer Res. 2016 Dec 15;22(24):6153–63. PMID: 27384421; PMCID: PMC5161635.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2292b707521692834f21cb54cfe25464
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be199c60ed488b003718457397e9faa0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8613-1890
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1fed31ae59b8f65c679ef9dc8050eab5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99c472bd8554809a2ae8e4224f4ab9aa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5dc1f5fde5dcd269189c625fc76a010
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cf4ead013934754e4bd78f40b2e7463
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1c4be7baac29f26458e23b6cb4eaf04
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36bccebc92101cf66e9ab03308f60ab2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bd2e339589e74703c703a5c8c381401
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91f2eea9eba7cc8c859098a9aa1e9c3d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76c2d31bfb681ad4de1a16040dd378ce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0082-6833
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_abf6ead7a2763213786920567c15120f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9515d2287938fdcac98cf2a8d976c1f1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6dca4dfd1882176fff13835228e54fed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b51c5ba744985addd4d4bc70af362862
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09da94a599fcc3ace29f76788076cd22
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d34c9d753260585207e0e6768a7dec9b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ba29a9f633130a73f147351f82dbcc4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_819abf18a8953909d21a206bd93ab0cb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db8b41c3673903dcbbcdb3b921128f4e
date 2016-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1158/1078-0432.ccr-16-0149
https://pubmed.ncbi.nlm.nih.gov/27384421
https://pubmed.ncbi.nlm.nih.gov/PMC5161635
isPartOf https://portal.issn.org/resource/ISSN/1557-3265
https://portal.issn.org/resource/ISSN/1078-0432
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3–MYC Interactions as a Target in Pancreatic Cancer
discusses http://id.nlm.nih.gov/mesh/M0016488
http://id.nlm.nih.gov/mesh/M0195291
http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0006674
http://id.nlm.nih.gov/mesh/M0006609
http://id.nlm.nih.gov/mesh/M0007613
http://id.nlm.nih.gov/mesh/M0042303
http://id.nlm.nih.gov/mesh/M0282623
http://id.nlm.nih.gov/mesh/M0000897
http://id.nlm.nih.gov/mesh/M0024867
http://id.nlm.nih.gov/mesh/M0261519
http://id.nlm.nih.gov/mesh/M0006678
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D004268Q000378
http://id.nlm.nih.gov/mesh/D004265Q000378
http://id.nlm.nih.gov/mesh/D016271Q000378
http://id.nlm.nih.gov/mesh/D010190Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D010190Q000473
http://id.nlm.nih.gov/mesh/D010190Q000188
http://id.nlm.nih.gov/mesh/D015398Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D064593Q000378
http://id.nlm.nih.gov/mesh/D010190
http://id.nlm.nih.gov/mesh/D016513
http://id.nlm.nih.gov/mesh/D021441Q000473
http://id.nlm.nih.gov/mesh/D011725Q000494
http://id.nlm.nih.gov/mesh/D010616Q000494
http://id.nlm.nih.gov/mesh/D054460Q000378
http://id.nlm.nih.gov/mesh/D041681
http://id.nlm.nih.gov/mesh/D004224Q000494
http://id.nlm.nih.gov/mesh/D049109Q000187
http://id.nlm.nih.gov/mesh/D015972Q000187
http://id.nlm.nih.gov/mesh/D014158Q000187
http://id.nlm.nih.gov/mesh/D021441Q000188
http://id.nlm.nih.gov/mesh/D002460
http://id.nlm.nih.gov/mesh/D004852Q000494
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D000577Q000494
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448042
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_086671f4507e548c21ced3a1195e1832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107985
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6f63d442fb1dfa33167c5c5ae7e5dd15
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7156

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2071

Total number of triples: 100.